Wells Fargo’s Emergent Biosolutions EBS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$292K Buy
45,691
+34,615
+313% +$221K ﹤0.01% 4145
2025
Q1
$53.8K Buy
11,076
+2,729
+33% +$13.3K ﹤0.01% 4920
2024
Q4
$79.8K Sell
8,347
-11,665
-58% -$112K ﹤0.01% 4830
2024
Q3
$167K Buy
20,012
+16,477
+466% +$138K ﹤0.01% 4307
2024
Q2
$24.1K Sell
3,535
-18,771
-84% -$128K ﹤0.01% 5157
2024
Q1
$56.4K Buy
22,306
+2,506
+13% +$6.34K ﹤0.01% 4831
2023
Q4
$47.5K Buy
19,800
+2,430
+14% +$5.83K ﹤0.01% 4874
2023
Q3
$59.1K Sell
17,370
-110,265
-86% -$375K ﹤0.01% 4752
2023
Q2
$938K Buy
127,635
+37,261
+41% +$274K ﹤0.01% 3331
2023
Q1
$936K Buy
90,374
+71,435
+377% +$740K ﹤0.01% 3202
2022
Q4
$224K Buy
18,939
+8,252
+77% +$97.5K ﹤0.01% 3856
2022
Q3
$224K Sell
10,687
-164,923
-94% -$3.46M ﹤0.01% 3913
2022
Q2
$5.45M Sell
175,610
-113,540
-39% -$3.52M ﹤0.01% 1939
2022
Q1
$11.9M Sell
289,150
-26,682
-8% -$1.1M ﹤0.01% 1625
2021
Q4
$13.7M Sell
315,832
-101,319
-24% -$4.4M ﹤0.01% 1535
2021
Q3
$20.9M Buy
417,151
+126,093
+43% +$6.31M ﹤0.01% 1580
2021
Q2
$18.3M Sell
291,058
-170,494
-37% -$10.7M ﹤0.01% 1693
2021
Q1
$42.9M Buy
461,552
+18,255
+4% +$1.7M 0.01% 1105
2020
Q4
$39.7M Sell
443,297
-164,414
-27% -$14.7M 0.01% 1110
2020
Q3
$62.8M Buy
607,711
+140,558
+30% +$14.5M 0.02% 761
2020
Q2
$36.9M Sell
467,153
-2,074
-0.4% -$164K 0.01% 1008
2020
Q1
$27.2M Buy
469,227
+158,422
+51% +$9.17M 0.01% 1071
2019
Q4
$16.8M Sell
310,805
-20,316
-6% -$1.1M ﹤0.01% 1572
2019
Q3
$17.3M Sell
331,121
-13,070
-4% -$683K ﹤0.01% 1527
2019
Q2
$16.6M Buy
344,191
+187,359
+119% +$9.05M ﹤0.01% 1573
2019
Q1
$7.92M Buy
156,832
+10,342
+7% +$523K ﹤0.01% 2115
2018
Q4
$8.69M Sell
146,490
-494
-0.3% -$29.3K ﹤0.01% 1940
2018
Q3
$9.68M Buy
146,984
+9,395
+7% +$618K ﹤0.01% 2082
2018
Q2
$6.95M Sell
137,589
-9,768
-7% -$493K ﹤0.01% 2376
2018
Q1
$7.76M Buy
147,357
+15,052
+11% +$793K ﹤0.01% 2221
2017
Q4
$6.15M Buy
132,305
+41,169
+45% +$1.91M ﹤0.01% 2390
2017
Q3
$3.69M Buy
91,136
+17,324
+23% +$701K ﹤0.01% 2761
2017
Q2
$2.5M Buy
73,812
+242
+0.3% +$8.21K ﹤0.01% 2994
2017
Q1
$2.14M Sell
73,570
-30,777
-29% -$894K ﹤0.01% 3121
2016
Q4
$3.43M Sell
104,347
-146,907
-58% -$4.82M ﹤0.01% 2678
2016
Q3
$7.92M Buy
251,254
+164,359
+189% +$5.18M ﹤0.01% 1916
2016
Q2
$2.44M Buy
86,895
+8,312
+11% +$234K ﹤0.01% 2799
2016
Q1
$2.86M Buy
78,583
+6,610
+9% +$240K ﹤0.01% 2654
2015
Q4
$2.88M Buy
71,973
+15,882
+28% +$636K ﹤0.01% 2689
2015
Q3
$1.6M Buy
56,091
+33,577
+149% +$956K ﹤0.01% 3106
2015
Q2
$742K Buy
22,514
+10,121
+82% +$334K ﹤0.01% 3771
2015
Q1
$356K Sell
12,393
-3,589
-22% -$103K ﹤0.01% 4042
2014
Q4
$435K Buy
15,982
+51
+0.3% +$1.39K ﹤0.01% 3933
2014
Q3
$340K Sell
15,931
-1,529
-9% -$32.6K ﹤0.01% 4038
2014
Q2
$392K Buy
17,460
+2,098
+14% +$47.1K ﹤0.01% 3971
2014
Q1
$388K Buy
15,362
+4
+0% +$101 ﹤0.01% 3955
2013
Q4
$353K Sell
15,358
-96
-0.6% -$2.21K ﹤0.01% 3929
2013
Q3
$294K Buy
15,454
+4,565
+42% +$86.8K ﹤0.01% 3986
2013
Q2
$157K Buy
+10,889
New +$157K ﹤0.01% 4195